Efficacy and safety of first-line immunotherapy for advanced gastric or gastroesophageal cancer: System review network meta-analysis

被引:0
|
作者
Qin, Qiong
Sun, Yongkun
Yang, Lin
Zhong, Diansheng
机构
[1] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16014
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Comparative efficacy and safety of immunotherapy in the first-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis
    Liu, Zheran
    Chen, Ye
    Wei, Zhigong
    He, Yan
    Wang, Jingjing
    Mu, Xiaoli
    He, Ling
    Li, Ruidan
    Hu, Xiaolin
    Peng, Xingchen
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 2805 - +
  • [22] Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
    Wu, Dong-Mei
    Wang, Yong-Jian
    Fan, Shao-Hua
    Zhuang, Juan
    Zhang, Zi-Feng
    Shan, Qun
    Han, Xin-Rui
    Wen, Xin
    Li, Meng-Qiu
    Hu, Bin
    Sun, Chun-Hui
    Bao, Ya-Xing
    Xiao, Hai-Juan
    Yang, Lin
    Lu, Jun
    Zheng, Yuan-Lin
    ONCOTARGET, 2017, 8 (59) : 100668 - 100677
  • [23] Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis
    Boutros, Andrea
    Tanda, Enrica Teresa
    Croce, Elena
    Catalano, Fabio
    Ceppi, Marcello
    Bruzzone, Marco
    Cecchi, Federica
    Arecco, Luca
    Fraguglia, Matteo
    Pronzato, Paolo
    Genova, Carlo
    Del Mastro, Lucia
    Lambertini, Matteo
    Spagnolo, Francesco
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 64 - 79
  • [24] Efficacy and safety of first line chemotherapy in Advanced EsophagoGastric Cancer (AEGC): A network meta-analysis
    Ter Veer, E.
    Mohammad, N. Haj
    Van Valkenhoef, G.
    Ngai, L. L.
    Mali, R.
    Van Oijen, M. G. H.
    Van Laarhoven, H. W. M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S459 - S459
  • [25] Immune Checkpoint Inhibitor Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis
    Zhang, Lianghui
    Huang, Lingli
    Liu, Zhixian
    Ling, Tao
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [26] Comparison of the efficacy and safety of third-line treatments for advanced gastric cancer: A systematic review and network meta-analysis
    Zhang, Chan
    Xiang, Yaoxian
    Wang, Jing
    Yan, Dong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Comparison of Efficacy and Safety of First-Line Chemoimmunotherapy in Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis
    Ma, Xiaolu
    Ding, Yongfeng
    Qian, Jiong
    Wan, Mingyu
    Chen, Xiaoyu
    Xu, Nong
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023, 2023
  • [28] Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
    Guven, Deniz Can
    Stephen, Bettzy
    Sahin, Taha Koray
    Cakir, Ibrahim Yahya
    Aksoy, Sercan
    LARYNGOSCOPE, 2024, 134 (01): : 7 - 17
  • [29] Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis
    Chen, Cong
    Zhang, Fan
    Zhou, Ning
    Gu, Yan-Mei
    Zhang, Ya-Ting
    He, Yi-Di
    Wang, Ling
    Yang, Lu-Xi
    Zhao, Yang
    Li, Yu-Min
    ONCOIMMUNOLOGY, 2019, 8 (05):
  • [30] A systematic review and meta-analysis to evaluate the efficacy and safety of nivolumab for advanced esophageal, gastroesophageal, and gastric cancer.
    Oyenuga, Mosunmoluwa
    Mohamed, Mohamed G.
    Sartaj, Sara
    Patel, Rushin
    Lacasse, Alexandre
    Mehta, Mudresh
    Sen, Sandeep
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16060 - E16060